DD296276B5 - Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung - Google Patents

Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung Download PDF

Info

Publication number
DD296276B5
DD296276B5 DD34235090A DD34235090A DD296276B5 DD 296276 B5 DD296276 B5 DD 296276B5 DD 34235090 A DD34235090 A DD 34235090A DD 34235090 A DD34235090 A DD 34235090A DD 296276 B5 DD296276 B5 DD 296276B5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen atom
triaza
tris
carboxymethyl
complex
Prior art date
Application number
DD34235090A
Other languages
German (de)
English (en)
Inventor
Heribert Dr Schmitt-Willich
Johannes Dr Platzek
Heinz Dr Gries
Gabriele D Schuhmann-Giampieri
Hubert Dr Vogler
Hanns-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6384290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD296276(B5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD296276B5 publication Critical patent/DD296276B5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94—Bismuth compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD34235090A 1989-06-30 1990-06-29 Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung DD296276B5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3922005A DE3922005A1 (de) 1989-06-30 1989-06-30 Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DD296276B5 true DD296276B5 (de) 1995-11-02

Family

ID=6384290

Family Applications (1)

Application Number Title Priority Date Filing Date
DD34235090A DD296276B5 (de) 1989-06-30 1990-06-29 Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung

Country Status (23)

Country Link
EP (1) EP0405704B1 (fr)
JP (1) JP2603357B2 (fr)
KR (1) KR100190808B1 (fr)
AT (1) ATE115546T1 (fr)
AU (1) AU637111B2 (fr)
CA (1) CA2020142C (fr)
CZ (1) CZ277926B6 (fr)
DD (1) DD296276B5 (fr)
DE (3) DE3922005A1 (fr)
DK (1) DK0405704T3 (fr)
ES (1) ES2066113T3 (fr)
FI (1) FI102168B1 (fr)
HU (1) HU210208B (fr)
IE (1) IE65676B1 (fr)
IL (1) IL94818A (fr)
NL (1) NL300182I2 (fr)
NO (2) NO179203C (fr)
NZ (1) NZ234295A (fr)
PT (1) PT94541B (fr)
RU (1) RU2086554C1 (fr)
TW (1) TW219356B (fr)
UA (1) UA27275C2 (fr)
ZA (1) ZA905129B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
DE4302287A1 (de) * 1993-01-25 1994-07-28 Schering Ag Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
DE4302289A1 (de) * 1993-01-25 1994-07-28 Schering Ag Verfahren zur Herstellung C-substituierter Diethylentriamine
DE4341724A1 (de) * 1993-12-03 1995-06-08 Schering Ag Halogenaryl-substituierte Metallkomplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
AU4173896A (en) * 1994-11-30 1996-06-19 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
TW319763B (fr) 1995-02-01 1997-11-11 Epix Medical Inc
DE19606326A1 (de) * 1995-02-09 1996-08-22 Schering Ag Kontrastmittelhaltige Liposomenformulierung sowie deren Verwendung für die In-vivo-Diagnostik, insbesondere für die Darstellung des Intravasalraumes
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
JP2759627B2 (ja) * 1995-07-21 1998-05-28 東北大学長 非エステル結合性ｄｔｐａ誘導体およびその製造方法
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
DE19712012A1 (de) * 1997-03-13 1998-09-24 Schering Ag Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6-9-tris(carboxymethyl)-4-(4- ethoxybenzyl)-undecandisäure
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
KR100749087B1 (ko) * 2006-06-02 2007-08-14 경북대학교 산학협력단 신규한 ｄｔｐａ-비스-아미드 리간드들 및 이들이 결합된가돌리늄 착물
SE533165C2 (sv) * 2008-06-13 2010-07-13 Chemseq Internat Ab Kemikalie och förfarande för komplexbindning av metalljoner, som är minst tvåvärda
EP2338874A1 (fr) * 2009-12-16 2011-06-29 Bracco Imaging S.p.A Procédé pour la préparation de composés chélatés
DE102010023890A1 (de) 2010-06-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecandinsäure und die Verwendung zur Herstellung von Primovist
US20130158241A1 (en) 2010-06-11 2013-06-20 Bayer Intellectual Property Gmbh Process for Preparing Crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic Acid and Use for Production of Primovist®
CN104761461A (zh) * 2014-09-09 2015-07-08 山东富创医药科技有限公司 一种新的钆塞酸二钠中间体的制备方法
EP3464237B1 (fr) * 2016-05-30 2023-12-20 Biophore India Pharmaceuticals Pvt. Ltd. Nouveau procédé pour la préparation de complexe de gadolinium d'acide (4s)-4-(4-éthoxybenzyl) -3,6,9-tris (carboxylatométhyl)-3,6,9-triazaundécanedioïque disodique (gadoxate disodique)
JP6867639B2 (ja) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 非イオン性ヨード造影剤の結合体
EP4059925A1 (fr) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft Nouvel agent de contraste pour une utilisation dans l'imagerie par résonance magnétique
EP4335840A1 (fr) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft Nouveaux agents de contraste pour l'imagerie diagnostique
EP4335462A1 (fr) 2022-09-09 2024-03-13 Bayer AG Nouveaux agents de contraste pour l'imagerie diagnostique par tomodensitometrie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
JP2833766B2 (ja) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト アミノポリカルボン酸およびその誘導体
AU617338B2 (en) * 1987-07-16 1991-11-28 Nycomed As Aminopolycarboxylic acids and derivatives thereof
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
CS9003174A2 (en) 1991-11-12
IE902299A1 (en) 1991-01-16
UA27275C2 (uk) 2000-09-15
CA2020142A1 (fr) 1990-12-31
AU637111B2 (en) 1993-05-20
EP0405704B1 (fr) 1994-12-14
ZA905129B (en) 1991-04-24
PT94541A (pt) 1991-02-08
JPH03215457A (ja) 1991-09-20
KR910000134A (ko) 1991-01-29
ES2066113T3 (es) 1995-03-01
NO179203C (no) 1996-08-28
CZ277926B6 (en) 1993-06-16
DE122004000051I2 (de) 2011-12-29
NL300182I1 (nl) 2005-06-01
HUT54622A (en) 1991-03-28
IE65676B1 (en) 1995-11-15
CA2020142C (fr) 2001-04-17
IL94818A0 (en) 1991-04-15
IL94818A (en) 1996-05-14
DE122004000051I1 (de) 2005-04-21
EP0405704A2 (fr) 1991-01-02
NO902925L (no) 1991-01-02
NO902925D0 (no) 1990-06-29
FI903295A0 (fi) 1990-06-29
FI102168B (fi) 1998-10-30
ATE115546T1 (de) 1994-12-15
DK0405704T3 (da) 1995-02-20
AU5802490A (en) 1991-01-03
NO2005013I2 (no) 2006-06-19
HU904040D0 (en) 1990-12-28
DE59007987D1 (de) 1995-02-02
IE902299L (en) 1990-12-30
PT94541B (pt) 1997-02-28
DE3922005A1 (de) 1991-01-10
HU210208B (en) 1995-02-28
EP0405704A3 (en) 1991-03-27
KR100190808B1 (ko) 1999-06-01
JP2603357B2 (ja) 1997-04-23
NZ234295A (en) 1993-02-25
RU2086554C1 (ru) 1997-08-10
HK1002810A1 (zh) 1998-09-18
NL300182I2 (nl) 2005-08-01
FI102168B1 (fi) 1998-10-30
NO179203B (no) 1996-05-20
TW219356B (fr) 1994-01-21

Similar Documents

Publication Publication Date Title
DD296276B5 (de) Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
EP0450742B1 (fr) DTPA-monoamides, compositions pharmaceutiques les contenant, leur utilisation et procédé pour leur préparation
EP0485045B1 (fr) Dérivés du 1,4,7,10-Tétraazacyclododécane-mono-N-substitués, leur procédé de préparation et produits pharmaceutiques les contenant
AT397465B (de) Diagnostisches mittel
US6039931A (en) Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
EP0352218B1 (fr) Composés polyaza macrocycliques, leur procédé de préparation et compositions pharmaceutiques les contenant
WO1996016929A1 (fr) Nouveaux derives de dtpa a plusieurs substituants, leurs complexes metalliferes, formulations pharmaceutiques contenant ces complexes et leur utilisation en diagnostic et en therapie, procedes de preparation des agents complexants et des complexes eux-memes et procedes de preparation des formulations pharmaceutiques
DE19525924A1 (de) Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0448191A1 (fr) 1,4,7,10-Tetraazacyclododécane-butyltriols, procédé pour leur préparation et agents pharmaceutiques les contenant
US5798092A (en) Derivatized DTPA complexes pharmaceutical agents containing these compounds, their use, and processes for their production
EP0680464B1 (fr) Complexes derives de dtpa, agents pharmaceutiques renfermant ces composes, leur utilisation comme produits de contraste pour rmn et radiographie, et leur procede de fabrication
EP0810989B1 (fr) Derives de dtpa a substitution nouvelle, leurs complexes metalliques, produits pharmaceutiques contenant ces complexes, leurs usages diagnostique et therapeutique, ainsi que procedes pour preparer ces complexes et produits pharmaceutiques
WO1997023245A1 (fr) Complexes polymeres en cascade, leur procede de preparation et agents pharmaceutiques les contenant
WO1995015306A1 (fr) Complexes metalliques substitues par halogenure d'aryle, substances pharmaceutiques contenant lesdits complexes, leur utilisation a des fins de diagnostic, et procedes de preparation desdists complexes et desdites substances pharmaceutiques
DE3633243A1 (de) Phosphonat-komplexe
DD296276A5 (de) Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltendepharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
DE19546234C1 (de) Neue makrobicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese makrobicyclischen Verbindungen enthaltende pharmazeutische Mittel
WO1991012822A1 (fr) Preparations pour diagnostic rm
HK1002810B (en) Dtpa-complexes derivatives, pharmaceutical compositions containing them, their use and process for their preparation
SK277828B6 (en) Complex dipa derivatives, pharmaceutical agents containing this compounds, their using and method of their production
DE3633246A1 (de) Amid-komplexe
EP1072604A1 (fr) Complexe de Calcium du (4R)-4-bis(carboxy-kappa.O)methyl amino-.kappa.N-6,9-bis (carboxy-.kappa.O)methyl-1-(4,4-diphenylcyclohexyl)oxy-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan- 11-oique-.kappa.N6,.kappa.N9,.kappa.O11 1-oxidato(6-)-,hexahydrogen, leurs sels, les médicaments contenant ces complexes, leur utilisation thérapeutique et comme additifs dans des agents de diagnostic ainsi qu'un procédé de préparation du complexe

Legal Events

Date Code Title Description
B5 Patent specification, 2nd publ. accord. to extension act
BAUF Maintained restricted (sect. 12/3 extension act)
IF04 In force in the year 2004

Expiry date: 20100630